Hubungan nya Pemakaian Asam Valproat Terhadap Perubahan Parameter Metabolisme Tulang Pada Penderita Epilepsi Idiopatik

DAFTAR PUSTAKA

1. Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan CT. Epidemiology,
aetiology and clinical management of epilepsy in Asia: Lancet Neurol. 2007;
6: 5333-43
2. Arzimanoglou AA, Guerrini R, Aicardi J. General principles of managment.
Dalam: Arzimanoglou AA, Guerrini R, Aicardi J, penyunting. Aichardis
epilepsy in children. Edisi ke-3. Philadelphia: Lippincott williams and wilkins;
2004. h.354-62
3. Valsanis HA, Arora SK, Labbab B, McFarlane SI. Antiepileptic drugs and
bone metabolism, nutrition dan metabolism. 2006; 3:36
4. Carney PW, Prowse MA, Scheffer IE. Epilepsy syndromes in children.
Australia Family Physician. 2005; 34: 1009-15
5. Naik N. Guidelines for diagnosis and management of childhood epilepsy.
Indian pediatrics.2009: 46:681 -98
6. Hwang H, Kim KJ. New antiepileptic drugs in pediatric epilepsi. Brain Dev.
2008 ;30:549 -55
7. Verrotti A, Coppola G, parisi P, Mohn A. Chiarelli. F. Bone and calcium
metabolism and antiepileptic drugs. Clinical Neurology and Neurosurgery.
2010; 1-10
8. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic

drugs. Cleve clin J Med. 2004. 71 Suppl 2;542-8
9. Babayigit A, Dirik E, Bober E, Cakmachi H. Adverse effects of antiepileptic
drugs on bone mineral clensity. Pediatr Neurol. 2006; 35: 177-81
10. Sheth RD. Bone Health in Epilepsy. International League Against Epilepsy
2002; 43(12):1453-4
11. M. Alism. Pack, the association between antiepileptic drugs and bone
disease. Epilepsy currents. 2003:91-5
12. Ecevit C, Aydogan A, Kavachi T, Altinoz S. Effect of karbamazepine and
valproate on bone mineral density. Pediatric Neural 2004; 31:279-82
13. Buluk A, Guzelipek M, Savh H, Temel I, Ozisik HI, Kaygusuz A. The effect
of valproate on bone mineral density in adult epileptic patients.
Pharmacological Research. 2004; 50:93-97
14. Ganong WF: Pengendalian hormonal pada metabolisme kalsium dan
fisiologi tulang. Dalam: Ganong WF, penyunting. Fisiologi Kedokteran Edisi
ke-17. Appleton and Lange, 1995.h.367-80
15. Holm IA. Disorders of bone metabolism. Dalam: Brook CG, Clayton PE,
Brown RS, Savage MO, penyunting. Clinical Pediatric Endocrinology. Edisi
ke-5. UK: Blackwell; 2005. h.280-519
16. Cashman KD. Diet, nutrition, and bone health. J Nutr 2007;137:2507s-12s
17. Kelenjar paratiroid, gangguan metabolisme tulang dan kalsium. Dalam:

Batubara JR, Tridjaja B, Pulungan AB, penyunting. Buku Ajar Endokrinologi
Anak. Edisi ke-1. Jakarta : BP IDAI, 2010.h.297-330
37

18. Flynn A. The role of dietary calcium in bone health. Proceedings Nutri
Society 2003; 62:851-8
19. Camfield PR, Camfield CS. Pediatric epilepsy: an overview. Dalam:
Swaimann KF, Ashwal S, Ferriero VM, penyunting. Pediatric Neurology
Principles & Practice. Edisi ke-1. Philadelphia: Mosby Inc; 2006.h.980-9.
20. Arzimanoglou A, Guerrini R, Aicardi J. Epilepsy: overview and definitions.
Dalam: Arzimanoglou A, Guerrini R, Aicardi J, penyunting. Aicardi’s
Epilepsy in Children. Edisi ke-3. USA: Maple press; 2004.h.1-7.
21. Panayiotopoulos CP. Principles of therapy in epilepsies. Dalam:
Panayiotopoulos CP, penyunting. The Epilepsies Seizures, Syndromes and
Management. Edisi ke-1. UK: Bladon medical publishing; 2005.h.59-80.
22. Conway JM, Kriel RL, Birnbaum AK. Antiepileptic drug therapy in children.
Dalam: Swaimann KF, Ashwal S, Ferriero VM, penyunting. Pediatric
Neurology Principles & Practice. Edisi ke-1. Philadelphia: Mosby Inc;
2006.h.1105-26
23. Arzimanoglou A, Guerrini R, Aicardi J. Medical treatment . Dalam:

Arzimanoglou A, Guerrini R, Aicardi J, penyunting. Aicardi’s Epilepsy in
Children. Edisi ke-3. USA: Maple press; 2004.h.363-86
24. Monti B, Polazzi E, Contestabile A. Biochemical, molecular, and epigenetic
mechanism of valproic acid neuroprotection. Curr Mol Pharmacol.
2009;2:95-109.
25. Thilothammal N, Banu K, Ratnam RS. Comparison of phenobarbitone,
phenytoin with sodium valproate:randomized, double-blind study. Indian J
Pediatr. 1996;33:549-55.
26. Noureen N, Rana MT. Does steady state serum level of valproic acid
correlate with dose, seiure response, and frequency of adverse drug
reactions in Pakistani children with epilepsy?. Pediatric Neurol.
2011;9:333-9.
27. Bourgeois BF.Valproate. Dalam: Pellock JM, Bourgeois RFD, Dodson WE,
Nordli DR, penyunting. Pediatric Epilepsy. Edisi ke-3 New
York:Demos;2008.h.685-98
28. Abaci A, Saygi M, Yis U, Demir K, Dirik E, Bober E. Metabolic alterations
during valproic acid treatment : a prospective study. Pediatric meurol. 2009;
41:435-9
29. A.Edgar, Samaniego, D. Raj, Sheth. Bone consequences of epilepsy and
antiepleptic medications. Semin Pediatr neutol. 2007; 14:196-200

30. Greer FR, Krebs NF. Comitee on Nutrition. Optimizing bone health and
calcium intakes of infants, children, and adolescents. Pediatrics 2006;
117:578-85
31. Lanou AJ, Berkow SE, Barnard ND. Calcium, Dairy Products, and Bone
Health in Children and Young Adults: A Reevaluation of the Evidence.
Pediatrics 2005;115:736-43
32. National Institu of Health Osteoporosis and Related Bone Disease, National
Resource Center. Calcium and Vitamin D: Important at Every Age.
38

33. Bueno AL, Czepielewski MA. The importance for growth of dietary intake of
calcium and vitamin D. J Pediatr. 2008; 84:386-94
34. Derman O, Cinemre A, Kanbur N, Dogan M, Kilic M, Karaduman E. Effect of
swimming on bone metabilsm in adolescents. Pediatrics. 2008; 50:149-54
35. Tekgul H, Serdaroglu G, Huseyinov A, Gokben S. Bone mineral status in
pediatric outpatients on antiepileptic drug monotherapy. Pediatrics. 2006;
21:411-414
36. Oner N, Karasalihoglu S, Karaca H, Celtik C, Tutunouler F. Bone mineral
metabolism changes in epileptic children receiving valproic acid. Pediatric
2004;40:470-473

37. Borusiak P, Langer T, Heruth M, Karenfort M, Bettendorf U, Jenke A CW.
Antiepileptic drug and bone metabolism in children: Data from 128 patients.
Pediatric. 2012;28:176-183

39